Back to search
FDAFDA · Food and drugs·Recall number D-0045-2024

Certain Over-The-Counter (OTC) drug products sold by Family Dollar retail stores.

Published October 25, 2023 · Recall initiated: October 5, 2023

Summary

FDA records drug Class II recall D-0045-2024, published October 25, 2023 and initiated October 5, 2023. Recalling firm: Dollar Tree Distribution, Inc.; Status: Ongoing; Reported quantity: 4,261,383 units of various products; Lot: Certain drug products sold by Family Dollar retail stores located in AL, AR, AZ, CA, CO, FL, GA, ID, KS, LA, MS, MT, ND, NE, NM, NV, OK, OR, SD, TX, UT, WA, and WY. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

CGMP Deviations: OTC products were stored outside of labeled temperature requirements.

What to do

Voluntary: Firm initiated · Press Release

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Dollar Tree Distribution, Inc.
Distributor
Nationwide in the USA
Lot
Certain drug products sold by Family Dollar retail stores located in AL, AR, AZ, CA, CO, FL, GA, ID, KS, LA, MS, MT, ND, NE, NM, NV, OK, OR, SD, TX, UT, WA, and WY.
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Certain Over-The-Counter (OTC) drug products sold by Family Dollar retail stores. recalled?

Yes. FDA published recall D-0045-2024 on October 25, 2023. Reported hazard: CGMP Deviations: OTC products were stored outside of labeled temperature requirements.

What should I do if I have this product?

Voluntary: Firm initiated · Press Release